GSS vs OCC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

54MEDIUM

OCC

ORTHOCELL FPO [OCC]

52MEDIUM

Score Breakdown

GSS OCC
Technical
50
45
Catalyst
65
55
Sentiment
50
50
Fundamental
59
83
Momentum
31
50
Risk Gate
50
45

Key Metrics

GSS Metric OCC
$14.5MMarket Cap$222.8M
877KAvg Volume (20d)527K
N/AShort Interest+0.4%
$0.43052-Week High$1.600
$0.05752-Week Low$0.700
-1.6%Daily Change-6.5%
$0.063Reference Price$0.795
-22.8%ROE-41.1%
-56.5%Profit Margin-133.8%

Active Signals

GSS Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (12 quarters)
Low P/S ratio (0.7x)
EPS estimates revised downward (-10pts)
Near 52-week low (2% of range)

OCC Signals

Drifting lower — down 5.9% over the last 5 days
Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (15 quarters)
4C filed 2026-07-12
Strong revenue growth (+49%)
EPS estimates revised upward (+10pts)
Near 52-week low (13% of range)

Ask Scout AI to compare GSS and OCC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

GSS vs PHX →GSS vs PKY →GSS vs RHY →HIQ vs ICR →HIQ vs IDX →
GSS Full Analysis → OCC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).